Results 161 to 170 of about 84,247 (263)
Clinical and Translational Discovery, Volume 6, Issue 5, October 2026.This review summarises the detection methods for severe fever with thrombocytopenia syndrome virus based on CRISPR platforms. (A) CRISPR with fluorescent reporter. (B) CRISPR with lateral flow test strip. (C) CRISPR with DNAzyme. (D) Digital CRISPR. (E) CRISPR with single micro‐ring resonator biosensor. (F) self‐amplifying signal amplification strategy
Junhu Wang +8 more
wiley +1 more source
Decoding sequence recognition code of nucleic acid‐binding proteins of human‐infecting DNA viruses
iMeta, Volume 5, Issue 5, October 2026.Human‐infecting DNA viruses remain major health threats, yet the DNA‐recognition mechanisms of their nucleic acid‐binding proteins (NBPs) are poorly understood. Here, we systematically profiled 103 viral NBPs from human‐infecting DNA viruses, with three NBPs from non‐human‐infecting DNA viruses as controls, using high‐throughput screening.
Meifang Tang +10 more
wiley +1 more source
SARS-CoV-2 Nucleocapsid (N) antibody (AB) values stratified according to sex.
SARS-CoV-2 Nucleocapsid (N) antibody (AB) values stratified according to sex.
Marianna Mitratza (18114764) +29 more
core +1 more source
Plasma Exchange for Hantavirus Pulmonary Syndrome: A Mechanistic Case for an Untested Intervention
Journal of Clinical Apheresis, Volume 41, Issue 5, October 2026.ABSTRACT Hantavirus pulmonary syndrome (HPS) carries a case fatality rate of 35%–40% and has no approved pharmacologic treatment. Its pathophysiology is rooted in the plasma compartment: cytokines, viral antigens, immune complexes, and platelet‐binding glycoproteins circulate as drivers of immunopathologic endothelial injury, noncardiogenic pulmonary ...
Menatalla Nadim +2 more
wiley +1 more source
eJHaem, Volume 7, Issue 5, October 2026.ABSTRACT Prolonged SARS‐CoV‐2 PCR positivity is increasingly recognized in immunocompromised patients. We retrospectively analyzed four patients with B‐cell lymphoma and prior anti‐CD20 antibody therapy who exhibited prolonged PCR positivity after COVID‐19 diagnosis.
Yutaka Natori +4 more
wiley +1 more source
Sigma‐1 Receptor‐Targeting Compounds Show Antiviral Activity Across Multiple Coronavirus Models
Journal of Medical Virology, Volume 98, Issue 10, October 2026.ABSTRACT Over the past two decades, coronaviruses have caused three major public health crises, including the epidemics of SARS‐CoV, MERS‐CoV, and SARS‐CoV‐2. Following the outbreak of SARS‐CoV‐2, several antiviral drugs have been approved for the treatment of COVID‐19.
Cuiling Zhang +9 more
wiley +1 more source
Journal of Medical Virology, Volume 98, Issue 10, October 2026.ABSTRACT Pathophysiological mechanisms of neurological manifestations in COVID‐19 are not fully known yet. In this case‐control study, proteomic analysis was used to characterize cerebrospinal fluid (CSF) samples from COVID‐19 patients with acute neurological manifestations primarily categorized as: isolated refractory headache (n = 12), encephalopathy
Nicole Lardini Freitas +8 more
wiley +1 more source
VIEW, Volume 7, Issue 5, October 2026.2D nanosheets, with large surface area, excellent optical/electrical properties, and high specificity, combine with lateral flow assay strips to enable rapid, readable detection, boosting the strips’ development and applications. Abstract Lateral flow assays (LFAs) are widely used for point‐of‐care diagnostics, but their detection capability remains ...
Weimin Xu +11 more
wiley +1 more source